This Week
  • IV4 Inc. has managed to grow steadily over the years.

  • $6.8 million redevelopment project aims to help create unique neighborhood.

  • Michael Gioja is guiding information technology advances at Paychex Inc.

  • Shaina Sidoti's firm makes nutritious dishes that have helped her heal.

  • Changes to New York's estate tax have reduced the cost of dying here.

  • Area exporters starting 2014 with a sense of momentum.

FDA gives marketing OK for B&L lenses

Rochester Business Journal
October 3, 2013

The Food and Drug Administration has cleared Bausch & Lomb Inc.’s new frequent replacement silicone hydrogel contact lenses with MoistureSeal, officials of the eye-care company’s Canadian parent company announced Thursday.

The FDA clearance came through sooner than expected, Valeant Pharmaceuticals International Inc. chairman and CEO Michael Pearson said.

The addition of MoistureSeal technology to the company’s silicone hydrogel lenses—portrayed by the company as the first significant breakthrough in the silicone hydrogel category—would give Bausch & Lomb’s contact lens business a significant boost, Pearson predicted.
    
(c) 2013 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail service@rbj.net.
 


 


What You're Saying 

There are no comments yet. Be the first to add yours!

Post Your Own Comment

 
Username:
Password:

Not registered? Sign up now!
 

To Do   Text Size
Post CommentPost A Comment eMail Size1
View CommentsView All Comments PrintPrint Size2
ReprintsReprints Size3
  • E-mailed
  • Commented
  • Viewed
RBJ   Google